These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 39289042)

  • 1. Corrigendum to "Secretory Nogo-B regulates Th2 differentiation in the lung cancer microenvironment" [Int. Immunopharmacol. 140 (2024) 112763].
    Qin C; Li W; Zhang Y; Wang Z; Leng Y; Ma J; Qin C; Cheng S; Xue L; Song K; Huang B
    Int Immunopharmacol; 2024 Dec; 142(Pt A):113108. PubMed ID: 39289042
    [No Abstract]   [Full Text] [Related]  

  • 2. Secretory Nogo-B regulates Th2 differentiation in the lung cancer microenvironment.
    Qin C; Li W; Zhang Y; Wang Z; Leng Y; Ma J; Qin C; Cheng S; Xue L; Song K; Huang B
    Int Immunopharmacol; 2024 Oct; 140():112763. PubMed ID: 39083925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corrigendum to "Rapamycin regulates osteogenic differentiation through Parkin-mediated mitophagy in rheumatoid arthritis" [Int. Immunopharmacol. 113(Part B) (2022) 109407].
    Chen Q; Fan K; Song G; Wang X; Zhang J; Chen H; Qin X; Lu Y; Qi W
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110941. PubMed ID: 37718175
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Berberine regulates PADI4-related macrophage function to prevent lung cancer" [Int. Immunopharmacol. 110 (2022) 108965].
    Gu W; Zhang M; Gao F; Niu Y; Sun L; Xia H; Li W; Zhang Y; Guo Z; Du G
    Int Immunopharmacol; 2023 Jul; 120():110366. PubMed ID: 37258402
    [No Abstract]   [Full Text] [Related]  

  • 5. Corrigendum to "Methionine enkephalin inhibited cervical cancer migration as well as invasion and activated CD11b+ NCR1+ NKs of tumor microenvironment" [Int. Immunopharmacol. 124(Pt B) (2023) 110967. doi: 10.1016/j.intimp.2023.110967. Epub 2023 Sep 21.].
    Qu N; Meng Y; Zhai J; Griffin N; Shan Y; Gao Y; Shan F
    Int Immunopharmacol; 2024 Sep; 139():112734. PubMed ID: 39069388
    [No Abstract]   [Full Text] [Related]  

  • 6. Corrigendum to "Notch2-dependent GATA3+ Treg cells alleviate allergic rhinitis by suppressing the Th2 cell response" [Int. Immunopharmacol. 112 (2022) 109261].
    Jiao WE; Xu S; Qiao YL; Kong YG; Sun L; Deng YQ; Yang R; Tao ZZ; Hua QQ; Chen SM
    Int Immunopharmacol; 2024 Jul; 136():112164. PubMed ID: 38852005
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Zerumbone enhances the Th1 response and ameliorates ovalbumin-induced Th2 responses and airway inflammation in mice" [Int. Immunopharmacol. 24 (2015) 383-391].
    Shieh YH; Huang HM; Ching-Chiung Wang ; Lee CC; Fan CK; Lee YL
    Int Immunopharmacol; 2017 Sep; 50():371. PubMed ID: 28751107
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Oridonin regulates the polarized state of Kupffer cells to alleviate nonalcoholic fatty liver disease through ROS-NF-κB" [Int. Immunopharmacol. 101(Part B) (2021) 108290].
    Zhu Y; Ruan S; Shen H; Guan Q; Zhai L; Yang Y
    Int Immunopharmacol; 2023 Jun; 119():110302. PubMed ID: 37193623
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "Corrigendum to "MLL1 promotes migration and invasion of fibroblast-like synoviocytes in rheumatoid arthritis by activating the TRIF/NF-κB signaling pathway via H3K4me3 enrichment in the TLR4 promoter region"" [Int. Immunopharmacol. 82 (2020) 106220] [Int. Immunopharmacol. 92 (2021) 107321].
    Zhang Y; Ji T; Ma S; Wu W
    Int Immunopharmacol; 2023 Apr; 117():109865. PubMed ID: 36822094
    [No Abstract]   [Full Text] [Related]  

  • 10. Epithelial reticulon 4B (Nogo-B) is an endogenous regulator of Th2-driven lung inflammation.
    Wright PL; Yu J; Di YP; Homer RJ; Chupp G; Elias JA; Cohn L; Sessa WC
    J Exp Med; 2010 Nov; 207(12):2595-607. PubMed ID: 20975041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corrigendum to "MicroRNA-208-5p regulates myocardial injury of sepsis mice via targeting SOCS2-mediated NF-κB/HIF-1α pathway" [Int. Immunopharmacol. 81 (2020) 106204].
    Ouyang H; Tan Y; Li Q; Xia F; Xiao X; Zheng S; Lu J; Zhong J; Hu Y
    Int Immunopharmacol; 2022 Mar; 104():108355. PubMed ID: 35058156
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "MEGF6 prevents sepsis-induced acute lung injury in mice" [Int. Immunopharmacol. 123 (2023) 110727].
    Liang H; Liu G; Zeng W; Fan Q; Nie Z; Hu H; Zhang R; Xie S
    Int Immunopharmacol; 2024 May; 133():111787. PubMed ID: 38641473
    [No Abstract]   [Full Text] [Related]  

  • 13. Corrigendum to "Plasma levels of 12 different cytokines correlate to PD-1 inhibitor combined chemotherapy responses in advanced non-small-cell lung cancer patient" [Int. Immunopharmacol. 124(Part A) (2023) 110888].
    Peng Y; Qi Q; Zhu M; Zhang Y; Bao Y; Liu Y
    Int Immunopharmacol; 2023 Nov; 124(Pt A):110976. PubMed ID: 37778965
    [No Abstract]   [Full Text] [Related]  

  • 14. Corrigendum to "Inhibition of MRP4 alleviates sepsis-induced acute lung injury in rats" [Int. Immunopharmacol. 72 (2019) 211-217].
    Xia W; Zhang H; Pan Z; Li G; Zhou Q; Hu D; Liu Y
    Int Immunopharmacol; 2023 Sep; 122():110699. PubMed ID: 37500384
    [No Abstract]   [Full Text] [Related]  

  • 15. Corrigendum to "Emodin attenuates acute lung injury in cecal-ligation and puncture rats" [Int. Immunopharmacol. 85 (2020) 106626].
    Guo R; Li Y; Han M; Liu J; Sun Y
    Int Immunopharmacol; 2023 Sep; 122():110700. PubMed ID: 37507324
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to "Artesunate ameliorates ligature-induced periodontitis by attenuating NLRP3 inflammasome-mediated osteoclastogenesis and enhancing osteogenic differentiation" [Int. Immunopharmacol. 123 (2023) 110749].
    Wang Z; Feng X; Zhang G; Li H; Zhou F; Xie Y; Li T; Zhao C; Luo W; Xiong Y; Wu Y
    Int Immunopharmacol; 2024 Dec; 142(Pt A):112999. PubMed ID: 39266370
    [No Abstract]   [Full Text] [Related]  

  • 17. Corrigendum to "Erastin enhances metastatic potential of ferroptosis-resistant ovarian cancer cells by M2 polarization through STAT3/IL-8 axis". [Int. Immunopharmacol. 113(Pt B) (2022) 109422].
    Cang W; Wu A; Gu L; Wang W; Tian Q; Zheng Z; Qiu L
    Int Immunopharmacol; 2024 Mar; 129():111651. PubMed ID: 38365538
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Sophoricoside attenuates lipopolysaccharide-induced acute lung injury by activating the AMPK/Nrf2 signaling axis" [Int. Immunopharmacol. 90 (2021) 107187].
    Wu YX; Zeng S; Wan BB; Wang YY; Sun HX; Liu G; Gao ZQ; Chen D; Chen YQ; Lu MD; Pang QF
    Int Immunopharmacol; 2023 Nov; 124(Pt A):111008. PubMed ID: 37806791
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Pmepa1 knockdown alleviates SpA-induced pyroptosis and osteogenic differentiation inhibition of hBMSCs via p38MAPK/NLRP3 axis" [Int. Immunopharmacol. 124(Part A) (2023) 110843].
    Li M; Shi X; Wu Y; Qi B; Zhang C; Wang B; Zhang B; Xu Y
    Int Immunopharmacol; 2023 Nov; 124(Pt A):111013. PubMed ID: 37806790
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Taxifolin ameliorates Benzo[a]pyrene-induced lung injury possibly via stimulating the Nrf2 signalling pathway" [Int. Immunopharmacol. 96 (2021) 107566].
    Islam J; Shree A; Vafa A; Afzal SM; Sultana S
    Int Immunopharmacol; 2023 Jun; 119():110096. PubMed ID: 37095029
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.